Agios Pharmaceuticals reports Q2 GAAP EPS of -$1.69 Agios Pharmaceuticals reported a Q2 GAAP EPS of -$1.69, missing by $0.02. The company's revenue was $44.75M, beating by $18.05M with a 259.1% year-over-year increase. As of June 30, 2026, Agios had $964.8 millio
Agios Pharmaceuticals reports Q2 GAAP EPS of -$1.69
Agios Pharmaceuticals reported a Q2 GAAP EPS of -$1.69, missing by $0.02.
The company’s revenue was $44.75M, beating by $18.05M with a 259.1% year-over-year increase.
As of June 30, 2026, Agios had $964.8 million in cash, cash equivalents, and marketable securities, down from $1.2 billion as of December 31, 2025.
ادخل بحساب جوجل لمشاركة رأيك والتفاعل مع الأخبار — بلا كلمة مرور.
إيميلك يبقى موثّقاً وخصوصيتك محفوظة.
